跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 806 条关于
“TILs”
全部
806
临床试验
619
药物
92
机构
8
资讯
87
去年
Global Standardization of TILs Assessment Marks Major Progress in Breast Cancer Research
去年
TILs Assessment Emerges as Powerful Tool for Personalizing Breast Cancer Treatment Decisions
去年
Selected TIL Therapy Combined with Pembrolizumab Shows Promising Results for Metastatic Gastrointestinal Cancers
去年
Biosyngen's Enhanced TIL Therapy Shows Promise in Liver Cancer Treatment
去年
High TIL Levels Could Enable Shorter Trastuzumab Treatment in Early ERBB2-Positive Breast Cancer
2年前
FDA Approves Lifileucel (Amtagvi): First TIL Therapy for Melanoma
去年
4D Path's Digital Biomarker Identifies Treatment Responders in Previously Resistant Breast Cancer Patients
2个月前
Mapping the Tumor Microenvironment: Immune Pathway Signatures Predict Immunotherapy Outcomes in Melanoma
2个月前
Feeder-Free TIL Expansion Platform Reduces IL-2 Dependence and Enhances Anti-Tumor Efficacy in Preclinical Study
去年
CD163+ Tumor-Associated Macrophages Linked to Improved Nivolumab Outcomes in Metastatic Renal Cell Carcinoma
第 1 页,共 9 页
上一页
下一页